[Federal Register Volume 86, Number 190 (Tuesday, October 5, 2021)]
[Notices]
[Page 54990]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21666]



[[Page 54990]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board and NCI Board of Scientific Advisors.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The meeting will be videocast and can be 
accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov/).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs 
and projects and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the 
intramural programs and projects, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 7, 2021.
    Closed: 12:00 p.m. to 1:00 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Open: 1:15 p.m. to 4:45 p.m.
    Agenda: NCAB Subcommittee Meetings--Subcommittee on Planning and 
Budget; Ad Hoc Subcommittee on Experimental Therapeutics; and Ad Hoc 
Subcommittee on Population Science, Epidemiology and Disparities.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 8, 2021.
    Open: 1:00 p.m. to 5:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Director's report and 
presentations, NCI Board of Scientific Advisors Concepts Review.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: December 9, 2021.
    Open: 1:00 p.m. to 5:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Board of Scientific Advisors 
Concepts Review and presentations.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Rockville, MD 20850 (Virtual Meeting).
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340, [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Institute's/Center's home 
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm, 
BSA: https://deainfo.nci.nih.gov/advisory/bsa/bsameetings.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 30, 2021.
Melanie Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21666 Filed 10-4-21; 8:45 am]
BILLING CODE 4140-01-P